Due to our active involvement in Manufacturing and interaction with various laboratories and manufacturers we are able to undertake Internationally acceptable quality of :

• Stability studies for Zone 4 countries
• BA / BE studies for Pharmaceuticals and Biologicals
• We can conduct BE/BA Studies for domestic and international markets.

Bioavailability Study: From a pharmacokinetic perspective, BA data for a given formulation provides an estimate of the relative fraction of the orally administered dose that is absorbed into the systemic circulation when compared to the BA data for a solution, suspension, or intravenous dosage form.

In addition, BA studies provide other useful pharmacokinetic information related to distribution, elimination, the effects of nutrients on the absorption of the drug, dose proportionality, linearity in the pharmacokinetics of the active moieties and, where appropriate, inactive moieties.

BA data can also provide information indirectly about the properties of a drug substance before entry into the systemic circulation, such as permeability and the influence of presystemic enzymes and/or transporters (e.g. p-glycoprotein).

Bioequivalence Study: As noted in the statutory definitions, both BE and product quality BA focus on the release of a drug substance from a drug product and subsequent absorption into the systemic circulation.